Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-043141
Filing Date
2024-04-03
Accepted
2024-04-03 16:55:35
Documents
6
Effectiveness Date
2024-04-03

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm248557d1_s8.htm S-8 58118
2 EXHIBIT 5.1 tm248557d1_ex5-1.htm EX-5.1 14194
3 EXHIBIT 23.1 tm248557d1_ex23-1.htm EX-23.1 2298
4 EX-FILING FEES tm248557d1_ex-filingfees.htm EX-FILING FEES 19570
5 GRAPHIC tm248557d1_ex5-1img001.jpg GRAPHIC 3440
6 GRAPHIC tm248557d1_ex5-1img002.jpg GRAPHIC 2185
  Complete submission text file 0001104659-24-043141.txt   103278
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278492 | Film No.: 24819760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)